← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2019Last known activity
Nov 4, 2025
Timeline
2010s
- Jun 1, 2013
Arvinas Inc— Founded
Drugs by trial phase (21 distinct, 27 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Indications
Studied for
Recent trials (27)
- NCT07231991CollaboratorPhase 1Nov 4, 2025
- NCT07023731Lead sponsorPhase 1/Phase 2May 29, 2025
- NCT06911788CollaboratorPhase 1Apr 3, 2025
- NCT06645938CollaboratorPhase 1Oct 24, 2024
- NCT06393738Lead sponsorPhase 1Sep 5, 2024
- NCT06347861CollaboratorPhase 1Apr 2, 2024
- NCT06275841CollaboratorPhase 1Feb 23, 2024
- NCT06206837CollaboratorPhase 1/Phase 2Feb 19, 2024
- NCT06256510CollaboratorPhase 1Feb 8, 2024
- NCT06125522CollaboratorPhase 2Nov 10, 2023
- NCT06005688CollaboratorPhase 1Aug 18, 2023
- NCT05909397CollaboratorPhase 3Aug 9, 2023
- NCT05930925CollaboratorPhase 1Jun 12, 2023
- NCT05732428CollaboratorPhase 1Feb 20, 2023
- NCT05673889CollaboratorPhase 1Jan 27, 2023
Details
- Founded
- New Haven, CT, US Jun 1, 2013
- Last known activity
- Nov 4, 2025